Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 15Breast Neoplasms 13Stomach Neoplasms 12Prostatic Neoplasms 12Colorectal Neoplasms 11Pancreatic Neoplasms 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Carcinoma, Hepatocellular 7Endometrial Neoplasms 5Colonic Neoplasms 4Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Gastrointestinal Stromal Tumors 3Gastrointestinal Neoplasms 3Esophageal Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Skin Neoplasms 2Salivary Gland Neoplasms 2Recurrence 2Rectal Neoplasms 2Peritoneal Neoplasms 2Papillomavirus Infections 2Obesity 2Multiple Myeloma 2

Interventions

lenvatinib 3Surgical Procedures, Operative 3Hepatectomy 3Cholangiopancreatography, Endoscopic Retrograde 3Blood Specimen Collection 3Oxaliplatin 2Liquid Biopsy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Drug Therapy 2Base Sequence 2pembrolizumab 1gemcitabine-oxaliplatin regimen 1envafolimab 1Vascular Endothelial Growth Factor A 1Urination 1Tegafur 1Shadowing Technique, Histology 1S 1 (combination) 1Radiotherapy 1Quality of Life 1Polymerase Chain Reaction 1Photochemotherapy 1Patient Reported Outcome Measures 1Pancreaticoduodenectomy 1Palliative Care 1Observation 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Microbiota 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cholangiocarcinoma × Observation × Clear all
NCT05292443 2024-02-23

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Geneplus-Beijing Co. Ltd.

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡